It is important to understand that the kidney disease was not caused by the treatment but, instead, was present all along
So, this is not a unique situation also, Ben, just for these two drugs of Eliquis and Xarelto, I truly believe that every other MFP drug will have significant issues with regards to access because of this increasing out of pocket costs that will occur because PBMs are going to fill the pressure of filling the void from the profitability that theyre going to lose
As the largest purchaser of health insurance in Massachusetts, were a crucial part of the effort, Sullivan said
Rybelsus 3 mg is the starting dose of Semaglutide taken once daily for 30 days
We have seen this happen, and this can be particularly problematic if your kidney function is already lower due to CKD." Patients with advanced CKD (eGFR between 1530 mL/min/1.73 m) or end-stage kidney disease (eGFR below 15 mL/min/1.73 m) require close monitoring since clinical data in these groups is limited
These conditions can cause changes in the blood that make clots more likely